Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages

Cited by (1,002)

Items 601–700 of 1,002

1. SARS-CoV-2 immunity in animal models
   Zhaoming Chen, Yaochang Yuan, Qingtao Hu, Ai-Ru Zhu, Fenghua Chen, Shu Li, Xin Guan, Chao Lv, Tian Tang, Yi-Yun He et al. · 2024 · Cellular & Molecular Immunology
2. Evaluation of coagulation status using viscoelastic testing in intensive care patients with coronavirus disease 2019 (COVID-19): An observational point prevalence cohort study
   Luke W Collett, Samuel Gluck, Richard Strickland, Benjamin A. J. Reddi · 2020 · Australian Critical Care
3. Characteristics of peripheral blood differential counts in hospitalized patients with COVID‐19
   Irene S. Pakos, Kevin Bryan Lo, Grace Salacup, Jerald Pelayo, Ruchika Bhargav, Eric Peterson, Fahad Gul, Robert DeJoy, Jeri Albano, Gabriel Patarroyo‐Aponte et al. · 2020 · European Journal Of Haematology
4. Parameters predicting COVID-19-induced myocardial injury and mortality
   Georg Daniel Duerr, Annkristin Heine, Marwan Hamiko, Sebastian Zimmer, Julian Alexander Luetkens, Jacob Nattermann, Gereon Jonas Rieke, Alexander Isaak, Julian Jehle, S Held et al. · 2020 · Life Sciences
5. Absolute Lymphocytes, Ferritin, C-Reactive Protein, and Lactate Dehydrogenase Predict Early Invasive Ventilation in Patients With COVID-19
   Salvador Payán‐Pernía, Lucía Gómez Pérez, Angel Francisco Remacha, Jordi Sierra Gil, Silvana Novelli · 2020 · Laboratory Medicine
6. Hypoxia reduces cell attachment of SARS-CoV-2 spike protein by modulating the expression of ACE2, neuropilin-1, syndecan-1 and cellular heparan sulfate
   Endika Prieto‐Fernández, Leire Egia‐Mendikute, Laura Vila-Vecilla, Alexandre Bosch, Adrián Barreira-Manrique, So Young Lee, Ana García-del Río, Asier Antoñana-Vildosola, Borja Jiménez-Lasheras, Leire Moreno‐Cugnon et al. · 2021 · Emerging Microbes & Infections
7. The Association of COVID-19 and Reactive Oxygen Species Modulator 1 (ROMO1) with Oxidative Stress
   Mohammad Amin Amini, Jamshid Karimi, Seyed Saman Talebi, Hosein Piri · 2022 · Chonnam Medical Journal
8. Macrophages derived from pluripotent stem cells: prospective applications and research gaps
   Irina V. Lyadova, Andrey Valentinovich Vasiliev · 2022 · Cell & Bioscience
9. Long-Term Sequelae of COVID-19 in Experimental Mice
   Michael John Paidas, Daniela S. Cosio, Saad Ali, Norma Sue Kenyon, Arumugam Radhakrishnan Jayakumar · 2022 · Molecular Neurobiology
10. Inflammation and vascular remodeling in COVID-19 hearts
    Christopher Werlein, Maximilian Ackermann, Helge Stark, Harshit Shah, Alexandar Tzankov, Jasmin D. Haslbauer, Saskia Freifrau von Stillfried, Roman David Bülow, Ali El‐Armouche, Stephan R. Künzel et al. · 2022 · Angiogenesis
11. Transmission of SARS-CoV-2 from mother to fetus or neonate: What to know and what to do?
    Danièle De Luca, Christelle Vauloup‐Fellous, Alexandra Benachi, Alexandre Joseph Vivanti · 2023 · Seminars in Fetal and Neonatal Medicine
12. Initial immune response after exposure to Mycobacterium tuberculosis or to SARS-COV-2: similarities and differences
    Alessandra Aiello, Saeid Najafi Fard, Delia Goletti · 2023 · Frontiers in Immunology
13. TRAIL promotes the polarization of human macrophages toward a proinflammatory M1 phenotype and is associated with increased survival in cancer patients with high tumor macrophage content
    Sinem Günalp, Derya Göksu Helvaci, Aysenur Oner, Ahmet Bursalı, Alessandra Jordano Conforte, Hüseyin Güner, Gökhan Karakülah, Éva Szegezdi, Duygu Sağ · 2023 · Frontiers in Immunology
14. Gut-brain pathogenesis of post-acute COVID-19 neurocognitive symptoms
    Allison M. Plummer, Yvette L. Matos, Henry C. Lin, Sephira G. Ryman, Aleksandr Birg, Davin K. Quinn, Alisha N. Parada, Andrei A. Vakhtin · 2023 · Frontiers in Neuroscience
15. New (re)purpose for an old drug: purinergic modulation may extinguish the COVID-19 thromboinflammatory firestorm
    Yogendra M. Kanthi, Jason S. Knight, Yu Zuo, David J. Pinsky · 2020 · JCI Insight
16. Potential Treatments for COVID-19 Related Cytokine Storm - Beyond Corticosteroids
    Yi Miao, Lei Fan, Jianyong Li · 2020 · Frontiers in Immunology
17. Immune response in SARS-CoV-2 infection: the role of interferons type I and type III
    Sousa Caciane, Carlos Roberto Brites · 2020 · The Brazilian Journal of Infectious Diseases
18. Investigation of CD26, a potential SARS-CoV-2 receptor, as a biomarker of age and pathology
    Animesh Alexander Raha, Subhojit Chakraborty, James W. Henderson, Elizabeta Blagoja Mukaetova-Ladinska, Shahid H. Zaman, John Trowsdale, Ruma Raha‐Chowdhury · 2020 · Bioscience Reports
19. Bronchoalveolar lavage fluid characteristics and outcomes of invasively mechanically ventilated patients with COVID-19 pneumonia in Genoa, Italy
    Chiara Dentone, Antonio Vena, Maurizio Loconte, Federica Grillo, Iole Brunetti, Emanuela Barisione, Elisabetta Tedone, Sara Mora, Antonio Di Biagio, Andrea Orsi et al. · 2021 · BMC Infectious Diseases
20. Role of Multiomics Data to Understand Host–Pathogen Interactions in COVID-19 Pathogenesis
    Shalini Aggarwal, Arup Acharjee, Amrita Mukherjee, Mark S. Baker, Sanjeeva Srivastava · 2021 · Journal of Proteome Research
21. Low Doses of Radiation Increase the Immunosuppressive Profile of Lung Macrophages During Viral Infection and Pneumonia
    Lydia Meziani, Charlotte Robert, Marion Classe, Bruno R. da Costa, Michele Mondini, Céline Clémenson, Alexia Alfaro, Pierre Mordant, Samy Ammari, Ronan Le Goffic et al. · 2021 · International Journal of Radiation Oncology*Biology*Physics
22. Molecular Pathology Analysis of SARS-CoV-2 in Syncytiotrophoblast and Hofbauer Cells in Placenta from a Pregnant Woman and Fetus with COVID-19
    Denise Morotti, Massimiliano Cadamuro, Elena Rigoli, Aurelio Sonzogni, Andrea Gianatti, Cristina Parolin, Luisa Patanè, David Asa Schwartz · 2021 · Pathogens
23. Combination Treatment With Remdesivir and Ivermectin Exerts Highly Synergistic and Potent Antiviral Activity Against Murine Coronavirus Infection
    Yu Ling Tan, Kevin S. W. Tan, Justin Jang Hann Chu, Vincent T. K. Chow · 2021 · Frontiers in Cellular and Infection Microbiology
24. APE1/Ref-1 – One Target with Multiple Indications: Emerging Aspects and New Directions
    Mahmut Mijit, Rachel A. Caston, Silpa Gampala, Melissa L. Fishel, Jill C. Fehrenbacher, Mark R. Kelley · 2021 · Journal of Cellular Signaling
25. Soluble TNF receptors predict acute kidney injury and mortality in critically ill COVID-19 patients: A prospective observational study
    Elena Sancho, Katja Hanslin, Michael Hultström, Anders Olof Larsson, Robert Frithiof, Miklós Lipcsey · 2021 · Cytokine
26. TNF-α+ CD4+ T cells dominate the SARS-CoV-2 specific T cell response in COVID-19 outpatients and are associated with durable antibodies
    Kattria van der Ploeg, Adam S. Kirosingh, Diego AM Mori, Saborni Chakraborty, Zicheng Hu, Benjamín L. Sievers, Karen Blake Jacobson, Hector Fabio Bonilla, Julie Parsonnet, Jason Randolph Andrews et al. · 2022 · Cell Reports Medicine
27. Severe COVID-19-associated variants linked to chemokine receptor gene control in monocytes and macrophages
    Bernard Stikker, Grégoire Stik, Antoinette F. van Ouwerkerk, Lianne Trap, Salvatore Spicuglia, Rudi W. Hendriks, Ralph Stadhouders · 2022 · Genome biology
28. Transcriptional reprogramming of infiltrating neutrophils drives lung pathology in severe COVID-19 despite low viral load
    Devon James Eddins, Junkai Yang, Astrid Kosters, Vincent D. Giacalone, Ximo Pechuan-Jorge, Joshua D. Chandler, Jinyoung Eum, Benjamin R. Babcock, Brian S. Dobosh, Mindy Hernandez et al. · 2022 · Blood Advances
29. Gastrointestinal Manifestations of SARS-CoV-2: Transmission, Pathogenesis, Immunomodulation, Microflora Dysbiosis, and Clinical Implications
    Siva Sundara Kumar Durairajan, Abhay Kumar Singh, Udhaya Bharathy Saravanan, Mayurikaa Namachivayam, Moorthi Radhakrishnan, Jian‐Dong Huang, Rahul Dhodapkar, Hongjie Zhang · 2023 · Viruses
30. The Role of IL-36 in Infectious Diseases: Potential Target for COVID-19?
    Xiaofang Wang, Panpan Yi, Yuejin Liang · 2021 · Frontiers in Immunology
31. Targeting alveolar macrophages: a promising intervention for pulmonary infection and acute lung injury
    Fei Hou, Nan Shi, Haoran Yuan, B. C. LI, Junjie Xiao, Kun Xiao, Lixin Xie · 2025 · Cellular & Molecular Biology Letters
32. Macrophage responses associated with COVID-19: A pharmacological perspective
    George W. Booz, Raffaele Altara, Ali Hussein Eid, Zena Wehbe, Souha A. Fares, Hassan Zaraket, Nada J. Habeichi, Fouad Anthony Zouein · 2020 · European Journal of Pharmacology
33. A connectivity map-based drug repurposing study and integrative analysis of transcriptomic profiling of SARS-CoV-2 infection
    Seyedeh Zahra Mousavi, Mojdeh Rahmanian, Ashkan Sami · 2020 · Infection Genetics and Evolution
34. Immune Response to SARS-CoV-2 Infection in Obesity and T2D: Literature Review
    Jorge Pérez, César Augusto Prócel Ramírez, Cristina Cañadas, Diana Aguirre, Ronny Pibaque, Ricardo Bedón-Galarza, Fernando Sempértegui, Hemmo A. Drexhage, Lucy Baldeón · 2021 · Vaccines
35. Janus kinase signaling as risk factor and therapeutic target for severe SARS‐CoV‐2 infection
    Farzan Solimani, Katharina Meier, Kamran Ghoreschi · 2021 · European Journal of Immunology
36. Possible role of purinergic signaling in COVID-19
    Maria Luiza Mukai Franciosi, Millena Daher Medeiros Lima, Maria Rosa Chitolina Schetinger, Andréia Machado Cardoso · 2021 · Molecular and Cellular Biochemistry
37. COVID-IRS: A novel predictive score for risk of invasive mechanical ventilation in patients with COVID-19
    José Antonio García-Gordillo, Antonio Camiro-Zúñiga, Mercedes Aguilar-Soto, Dalia Cuenca, Arturo Cadena‐Fernández, Latife Salame Khouri, Jesica Naanous Rayek, Moisés Mercado, The ARMII Study Group · 2021 · PLoS ONE
38. COVID-19 and Alzheimer’s Disease: A Literature Review
    Louis Hardan, Dimitar Filtchev, Ratiba Kassem, Rim Bourgi, Monika Łukomska−Szymańska, Hassan Tarhini, Fouad Salloum-Yared, Davide Mancino, Naji Kharouf, Youssef Haïkel · 2021 · Medicina
39. Alveolar macrophages: novel therapeutic targets for respiratory diseases
    Pamelia N. Lim, Maritza M. Cervantes, Linh K. Pham, Alissa C. Rothchild · 2021 · Expert Reviews in Molecular Medicine
40. SARS-CoV-2 induces mitochondrial dysfunction and cell death by oxidative stress/inflammation in leukocytes of COVID-19 patients
    Joel De la Cruz Enriquez, Emmanuel Rojas-Morales, María Gema Ruíz-García, Julio C. Tobón-Velasco, Jose Carlos Jimenez-Ortega · 2021 · Free Radical Research
41. Excessive IL-10 and IL-18 trigger hemophagocytic lymphohistiocytosis–like hyperinflammation and enhanced myelopoiesis
    Yuting Tang, Qian Xu, Hui Luo, Xiaomei Yan, Gaoxiang Wang, Liang Hu, Jin Jin, David P. Witte, Rebecca A. Marsh, Liang Huang et al. · 2022 · Journal of Allergy and Clinical Immunology
42. Therapeutic potential of C1632 by inhibition of SARS-CoV-2 replication and viral-induced inflammation through upregulating let-7
    Chen Xie, Yanlian Chen, Dongling Luo, Zhen Zhuang, Jin Heping, Haoxian Zhou, Xiaocui Li, Haijun Lin, Xiaohui Zheng, Jing Zhang et al. · 2021 · Signal Transduction and Targeted Therapy
43. Why is SARS-CoV-2 infection more severe in obese men? The gut lymphatics – Lung axis hypothesis
    Mathieu Uzzan, Olivier Corcos, J. P. D. Martin, Xavier Tréton, Yoram Bouhnik · 2020 · Medical Hypotheses
44. IL-9 aggravates SARS-CoV-2 infection and exacerbates associated airway inflammation
    Srikanth Sadhu, Rajdeep Dalal, Jyotsna Dandotiya, Akshay Binayke, Virendra Singh, Manas Ranjan Tripathy, Vinayaka Das, Sandeep Goswami, Shakti Kumar, Zaigham Abbas Rizvi et al. · 2023 · Nature Communications
45. Modeling Multi-organ Infection by SARS-CoV-2 Using Stem Cell Technology
    Camille R. Simoneau, Mélanie Ott · 2020 · Cell stem cell
46. A sensitive indicator for the severity of COVID-19: thiol
    Özcan Erel, Salim Neşeli̇oğlu, Merve Ergin Tunçay, Esra Fırat Oğuz, Funda Karakoyunlu Eren, Meryem Sena Akkuş, Rahmet Güner, İhsan Ateş · 2020 · TURKISH JOURNAL OF MEDICAL SCIENCES
47. Rationales and uncertainties for aspirin use in COVID-19: a narrative review
    Hazem A. Sayed Ahmed, Eric Merrell, Mansoura Ismail, Anwar Ibrahim Joudeh, Jeffrey B. Riley, Ahmed Shawkat, Hanan Habeb, Edward Darling, Reda Abdelmoaty Goweda, Mohamed Hany Shehata et al. · 2021 · Family Medicine and Community Health
48. COVID-19, Neuropathology, and Aging: SARS-CoV-2 Neurological Infection, Mechanism, and Associated Complications
    Rajkumar Singh Kalra, Jaspreet Kaur Dhanjal, Avtar S. Meena, Vishal C. Kalel, Surya Dahiya, Birbal Singh, Saikat Dewanjee, Ramesh J. L. Kandimalla · 2021 · Frontiers in Aging Neuroscience
49. The role of antigen-presenting cells in the pathogenesis of COVID-19
    Rana Farzi, Parisa Shiri Aghbash, Narges Eslami, Arezou Azadi, Ali Shamekh, Nima Hemmat, Taher Entezari‐Maleki, Hossein Bannazadeh Baghi · 2022 · Pathology - Research and Practice
50. Evaluation of individual and combined NLR, LMR and CLR ratio for prognosis disease severity and outcomes in patients with COVID-19
    Awatef Ben Jemaa, Noura Salhi, Meriam Ben Othmen, Hana Ben Ali, Jihene Guissouma, Hatem Ghadhoune, Ridha Oueslati, Hamdi Dhaouadi · 2022 · International Immunopharmacology
51. SARS-CoV-2 Achieves Immune Escape by Destroying Mitochondrial Quality: Comprehensive Analysis of the Cellular Landscapes of Lung and Blood Specimens From Patients With COVID-19
    Chenyang Duan, Ruiyan Ma, Xue Zeng, Bing Chen, Dongyao Hou, Ruixue Liu, Xuehan Li, Liangming Liu, Tao Li, He Huang · 2022 · Frontiers in Immunology
52. COVID-19: imbalanced cell-mediated immune response drives to immunopathology
    Jun Wang, Qian Li, Yuanwang Qiu, Hongzhou Lu · 2022 · Emerging Microbes & Infections
53. Clinical assessment of endothelial function in convalescent COVID-19 patients: a meta-analysis with meta-regressions
    Pasquale Ambrosino, Stefano Sanduzzi Zamparelli, Marco Mosella, Roberto Formisano, Antonio Molino, Giorgio Alfredo Spedicato, Antimo Papa, Andréa Motta, Matteo Nicola Dario Di Minno, Mauro Maniscalco · 2022 · Annals of Medicine
54. Distinct SARS-CoV-2 RNA fragments activate Toll-like receptors 7 and 8 and induce cytokine release from human macrophages and microglia
    Thomas E. Wallach, Martin Raden, Lukas Hinkelmann, Mariam Brehm, Dominik Rabsch, Hannah Weidling, Christina Krüger, Helmut Kettenmann, Rolf Backofen, Seija Lehnardt · 2023 · Frontiers in Immunology
55. Antiviral Molecular Targets of Essential Oils against SARS-CoV-2: A Systematic Review
    M. Iqhrammullah, D. Rizki, Agnia Purnama, T. F. Duta, H. Harapan, R. Idroes, B. Ginting · 2023 · Scientia Pharmaceutica
56. Identification of immunomodulatory drugs that inhibit multiple inflammasomes and impair SARS-CoV-2 infection
    Letícia de Almeida, Alexandre L. N. da Silva, Tamara Silva Rodrigues, Samuel Oliveira, Adriene Y. Ishimoto, Amanda Aparecida Seribelli, Amanda Becerra, Warrison A. Andrade, Marco A. Ataide, Camila Carla da Silva Caetano et al. · 2022 · Science Advances
57. Integrated metabolic-transcriptomic network identifies immunometabolic modulations in human macrophages
    Hung‐Jen Chen, Daniel C. Sévin, Guillermo R. Griffith, Johanna Vappiani, Lee M. Booty, Cindy P. A. A. van Roomen, Johan Kuiper, Jeroen den Dunnen, Wouter J. de Jonge, Rab K. Prinjha et al. · 2024 · Cell Reports
58. Systemic innate and adaptive immune responses to SARS-CoV-2 as it relates to other coronaviruses
    Patrick O’Connell, Yasser Ali Aldhamen · 2020 · Human Vaccines & Immunotherapeutics
59. Promising Therapy for Heart Failure in Patients with Severe COVID-19: Calming the Cytokine Storm
    Xiang Peng, Yani Wang, Xiangwen Xi, Ying Jia, Jiangtian Tian, Bo Yu, Jinwei Tian · 2021 · Cardiovascular Drugs and Therapy
60. Survival Analysis and Risk Factors in COVID-19 Patients
    Wen Lu, Shuhui Yu, Hailing Liu, Lihua Suo, Kuanyin Tang, Jitao Hu, Yantong Shi, Ke Hu · 2021 · Disaster Medicine and Public Health Preparedness
61. Comparative immune profiling of acute respiratory distress syndrome patients with or without SARS-CoV-2 infection
    Mikaël Roussel, Juliette Ferrant, Florian Reizine, Simon Le Gallou, Joëlle Dulong, Sarah H. Carl, Matheiu Lesouhaitier, Murielle Grégoire, Nadège Bescher, Clotilde Verdy et al. · 2021 · Cell Reports Medicine
62. Type 1 Diabetes Mellitus in the SARS-CoV-2 Pandemic: Oxidative Stress as a Major Pathophysiological Mechanism Linked to Adverse Clinical Outcomes
    Aikaterini Kountouri, Emmanouil Korakas, Ignatios Ikonomidis, Athanasios E. Raptis, Nikolaοs Tentolouris, George Dimitriadis, Vaia Lambadiari · 2021 · Antioxidants
63. Extracellular Vesicles and Citrullinated Histone H3 in Coronavirus Disease 2019 Patients
    Ludwig Traby, Marietta Kollars, Manuel Kussmann, Matthias Karer, Hana Šinkovec, Elisabeth Lobmeyr, Alexander Hermann, Thomas Staudinger, Peter Schellongowski, Bernhard Rössler et al. · 2021 · Thrombosis and Haemostasis
64. COVID-19: Lung-Centric Immunothrombosis
    Peter R. Kvietys, Hana M. A. Fakhoury, Sana Kadan, Ahmed Yaqinuddin, Eid Al Mutairy, Khaled Manae AlKattan · 2021 · Frontiers in Cellular and Infection Microbiology
65. THE PROTHROMBOTIC STATE ASSOCIATED WITH SARS-COV-2 INFECTION: PATHOPHYSIOLOGICAL ASPECTS
    Nicola Semeraro, Mario Colucci · 2021 · Mediterranean Journal of Hematology and Infectious Diseases
66. Inhaled nano-based therapeutics for inflammatory lung diseases: Recent advances and future prospects
    Nisha Gulati, Dinesh Kumar Chellappan, Ronan J. MacLoughlin, Kamal Dua, Harish Dureja · 2021 · Life Sciences
67. Severe Dysbiosis and Specific Haemophilus and Neisseria Signatures as Hallmarks of the Oropharyngeal Microbiome in Critically Ill Coronavirus Disease 2019 (COVID-19) Patients
    Juliana de Castilhos, Eli Zamir, Theresa Hippchen, Roman Rohrbach, Sabine Schmidt, Silvana Hengler, Hanna Schumacher, Melanie Neubauer, Sabrina Kunz, Tonia Müller-Esch et al. · 2021 · Clinical Infectious Diseases
68. A Multifunctional Neutralizing Antibody‐Conjugated Nanoparticle Inhibits and Inactivates SARS‐CoV‐2
    Xiaolei Cai, Min Chen, Aleksander Promiński, Yiliang Lin, Nicholas Ankenbruck, Jillian N. Rosenberg, Mindy Nguyen, Jiuyun Shi, Αναστασία Τοματσίδου, Glenn C. Randall et al. · 2021 · Advanced Science
69. Plasma microparticles of intubated COVID‐19 patients cause endothelial cell death, neutrophil adhesion and netosis, in a phosphatidylserine‐dependent manner
    Yohann Garnier, Livia Claude, Patricia Hermand, Evely Sachou, Aurélie Claës, Kassandra Desplan, Bassel Chahim, Pierre‐Marie Roger, Frédéric Martino, Yves Colin et al. · 2021 · British Journal of Haematology
70. COVID-19, Vaccines, and Thrombotic Events: A Narrative Review
    Maurizio Giuseppe Abrignani, Adriano Murrone, Leonardo De Luca, Loris Roncon, Andrea Di Lenarda, Serafina Valente, Pasquale Caldarola, Carmine Riccio, Fabrizio Giovanni Oliva, Michele Massimo Gulizia et al. · 2022 · Journal of Clinical Medicine
71. Understanding the epigenetic mechanisms in SARS CoV-2 infection and potential therapeutic approaches
    Swati Bhat, P. Rishi, V. Chadha · 2022 · Virus Research
72. Epigenetic perspectives associated with COVID-19 infection and related cytokine storm: an updated review
    Amit Dey, K. Vaishak, Dikshita Deka, Arunkumar Radhakrishnan, Sujay Paul, Priyadarshini Shanmugam, R Alice Peace Selvabai, Surajit Pathak, Asim K. Duttaroy, Antara Banerjee · 2023 · Infection
73. SARS-CoV-2 Related Antibody-Dependent Enhancement Phenomena In Vitro and In Vivo
    Emi E. Nakayama, Tatsuo Shioda · 2023 · Microorganisms
74. SARS-CoV-2 hijacks p38β/MAPK11 to promote virus replication
    Christina A. Higgins, Benjamin E. Nilsson-Payant, Andrew P. Kurland, Chengjin Ye, Томер Ярон, Jared Lee Johnson, Boris Bonaventure, Prithy Adhikary, Ilona Golynker, Maryline Panis et al. · 2023 · mBio
75. Single-cell transcriptomic analysis reveals a systemic immune dysregulation in COVID-19-associated pediatric encephalopathy
    Yi Wang, Laurence Don Wai Luu, Shuang Liu, Xiong Zhu, Siyuan Huang, Fang Li, Xiaolan Huang, Linying Guo, Jin Zhang, Haiyan Ge et al. · 2023 · Signal Transduction and Targeted Therapy
76. Non-canonical function of histone methyltransferase G9a in the translational regulation of chronic inflammation
    Adil Muneer, Li Wang, Ling Xie, Feng Zhang, Bing Wu, Mei Liu, Erik M. Lenarcic, Emerald Hillary Feng, Juan Song, Yan Xiong et al. · 2023 · Cell chemical biology
77. Disease severity-specific neutrophil signatures in blood transcriptomes stratify COVID-19 patients
    Anna C. Aschenbrenner, Maria Mouktaroudi, Benjamin Krämer, Nikolaos Antonakos, Marie Oestreich, Konstantina Gkizeli, Melanie Nuesch-Germano, Maria Saridaki, Lorenzo Bonaguro, Nico Reusch et al. · 2020 · medRxiv
78. ACE2-independent SARS-CoV-2 virus entry through cell surface GRP78 on monocytes – evidence from a translational clinical and experimental approach
    Bing Han, Yibing Lv, Dominique Moser, Xiaoqi Zhou, Tobias Woehrle, Lianyong Han, Andreas Osterman, Martina Rudelius, Alexander Choukèr, Ping Lei · 2023 · EBioMedicine
79. Navigating immunosuppression in a pandemic: A guide for the dermatologist from the COVID Task Force of the Medical Dermatology Society and Society of Dermatology Hospitalists
    Omid Zahedi Niaki, Milan J. Anadkat, Steven T. Chen, Lindy Peta Fox, JOANNA LEE HARP, Robert G. Micheletti, Vinod E. Nambudiri, Helena B. Pasieka, Michi M. Shinohara, Misha A. Rosenbach et al. · 2020 · Journal of the American Academy of Dermatology
80. Change of Antigenic Determinants of SARS-CoV-2 Virus S-Protein as a Possible Cause of Antibody-Dependent Enhancement of Virus Infection and Cytokine Storm
    Yu. D. Nechipurenko, Anastasia A. Anashkina, Olga V. Matveeva · 2020 · BIOPHYSICS
81. Future Biomarkers for Infection and Inflammation in Febrile Children
    Judith Zandstra, Ilse Jongerius, Taco Willem Kuijpers · 2021 · Frontiers in Immunology
82. Delirium and Inflammation in Older Adults Hospitalized for COVID-19: A Cohort Study
    Marie‐France Forget, Sophie Del Degan, Julie Leblanc, Rita Tannous, Michaël Desjardins, Madéleine Durand, Thien Tuong Minh Vu, Quôc Dinh Nguyên, Philippe Desmarais · 2021 · Clinical Interventions in Aging
83. The association between a lifestyle score, socioeconomic status, and COVID-19 outcomes within the UK Biobank cohort
    Hamish M. E. Foster, Frederick Ka Wing Ho, Frances S Mair, Bhautesh Jani, Naveed A. Sattar, Srinivasa Vittal Katikireddi, Jill P. Pell, Claire L. Niedzwiedz, Claire E. Hastie, Jana J. Anderson et al. · 2022 · BMC Infectious Diseases
84. Levocetirizine and montelukast in the COVID-19 treatment paradigm
    Bruce Chandler May, K. Holly Gallivan · 2021 · International Immunopharmacology
85. SARS-CoV-2 treatment effects induced by ACE2-expressing microparticles are explained by the oxidized cholesterol-increased endosomal pH of alveolar macrophages
    Zhenfeng Wang, Jiadi Lv, Pin Yü, Yajin Qu, Yabo Zhou, Li Zhou, Qiangqiang Zhu, Shunshun Li, Jiangping Song, Wei Deng et al. · 2022 · Cellular and Molecular Immunology
86. COVID-19, Oxidative Stress and Male Reproduction: Possible Role of Antioxidants
    Pallav Sengupta, Sulagna Dutta, Shubhadeep Roychoudhury, Urban J A D'Souza, G. Kadirvel, Adriana Kolesárová · 2022 · Antioxidants
87. Humanized mice reveal a macrophage-enriched gene signature defining human lung tissue protection during SARS-CoV-2 infection
    Devin Kenney, Aoife Kateri O’Connell, Jacquelyn Turcinovic, Paige Montanaro, Ryan Matthew Hekman, Tomokazu Tamura, Andrew R. Berneshawi, Thomas R. Cafiero, Salam Al Abdullatif, Benjamin C. Blum et al. · 2022 · Cell Reports
88. COVID-19 and Neurodegenerative Diseases: Prion-Like Spread and Long-Term Consequences
    Narjes Baazaoui, Khalid Iqbal · 2022 · Journal of Alzheimer s Disease
89. Autoimmunity after Coronavirus Disease 2019 (COVID-19) Vaccine: A Case of Acquired Hemophilia A
    Scott Farley, Robert J. Ousley, Nicholas Van Wagoner, Fernando Bril · 2021 · Thrombosis and Haemostasis
90. Histopathologic and Autopsy Findings in Patients Diagnosed With Coronavirus Disease 2019 (COVID-19): What We Know So Far Based on Correlation With Clinical, Morphologic and Pathobiological Aspects
    Areej Manssour Al Nemer · 2020 · Advances in Anatomic Pathology
91. COVID-19 associated complications and potential therapeutic targets
    Jasmin D. Monpara, Srushti Sodha, Pardeep Kumar Gupta · 2020 · European Journal of Pharmacology
92. Flow cytometric evaluation of the neutrophil compartment in COVID-19 at hospital presentation: A normal response to an abnormal situation
    Roy Spijkerman, Suzanne H Bongers, Bas J. J. Bindels, Gerjen Herman Tinnevelt, Giulio Giustarini, Nikita K. N. Jorritsma, Wiebe Buitenwerf, Daan E. J. van Spengler, Eveline M. Delemarre, Stefan Nierkens et al. · 2020 · Journal of Leukocyte Biology
93. Cell‐mediated immunity to SARS‐CoV‐2
    Xiaolin Wang, Jingang Gui · 2020 · Pediatric Investigation
94. Fusogenic porous silicon nanoparticles as a broad-spectrum immunotherapy against bacterial infections
    Byungji Kim, Qinglin Yang, Leslie W. Chan, Sangeeta N. Bhatia, Erkki Ruoslahti, Michael J. Sailor · 2021 · Nanoscale Horizons
95. Identification of SARS-CoV-2–specific immune alterations in acutely ill patients
    Rose‐Marie Rébillard, Marc Charabati, Camille Grasmuck, Abdelali Filali-Mouhim, Olivier Tastet, Nathalie Brassard, Audrey Daigneault, Lyne Bourbonnière, Sai Priya Anand, Renaud Balthazard et al. · 2021 · Journal of Clinical Investigation
96. The relationship between cytokine and neutrophil gene network distinguishes SARS-CoV-2–infected patients by sex and age
    Paula Paccielli Freire, Alexandre H. C. Marques, Gabriela C. Baiocchi, Lena F. Schimke, Dennyson Leandro M. Fonseca, Ranieri Coelho Salgado, Igor Salerno Filgueiras, Sarah Maria da Silva Napoleão, Desirée Rodrigues Plaça, Karen Tiemi Akashi et al. · 2021 · JCI Insight
97. TREM2 is thyroid hormone regulated making the TREM2 pathway druggable with ligands for thyroid hormone receptor
    Skylar J. Ferrara, Priya Chaudhary, Margaret J. DeBell, Gail Marracci, Hannah I. Miller, Evan Calkins, Edvinas Pocius, Brooke A. Napier, Ben Emery, DENNIS N. BOURDETTE et al. · 2021 · Cell chemical biology
98. Cellular and Molecular Effects of SARS-CoV-2 Linking Lung Infection to the Brain
    Linda Francistiová, Adrián Klepe, Géza Curley, Károly Gulya, András Dinnyés, Kata Filkor · 2021 · Frontiers in Immunology
99. Severe acute respiratory syndrome coronavirus 2 causes lung inflammation and injury
    Lele Wang, Jia‐Wei Yang, Jin‐Fu Xu · 2021 · Clinical Microbiology and Infection
100. microRNAs and Inflammatory Immune Response in SARS-CoV-2 Infection: A Narrative Review
     Beatrice Maranini, Giovanni Ciancìo, Manuela Ferracin, Rosario Cultrera, Massimo Negrini, Silvia Sabbioni, Marcello Govoni · 2022 · Life